Differences

This shows you the differences between two versions of the page.

--- national_advisory_committee_on_immunization [2022/04/22 09:21]
liam [Former]
+++ national_advisory_committee_on_immunization [2023/04/19 23:20] (current)
liam
@@ Line 3: / Line 3: @@
 {{ ::screen_shot_2022-03-19_at_1.13.01_am.png?200|}}
-The **National Advisory Committee on Immunization** (NACI) is a Canadian advisory body intended to act independently of, and in conjunction with, [[Health Canada]].
+The **National Advisory Committee on Immunization** (NACI) is a Canadian advisory body operating within the [[Public Health Agency of Canada]] (PHAC).((Public Health Agency of Canada. (2022, September 16). //National Advisory Committee on Immunization (NACI): Terms of reference.// Government of Canada. https://web.archive.org/web/20230406185629/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/terms-references.html)) It is tasked with "providing guidance on the use of [[vaccines]] currently or newly approved for use in Canada to the [[Government of Canada]]."((Public Health Agency of Canada. (2022, April 22). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))
-===== Members =====
+===== History =====
-==== Current ====
+NACI was formed in 1964.((Public Health Agency of Canada. (2022, April 22). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))
+==== COVID-19 ====
+On April 23, 2021, NACI recommended the [[covid-19_vaccines:Vaxzevria|AstraZeneca-Oxford COVID-19 vaccine]] be offered to "all Canadians over the age of 30, but only when the benefits outweigh the risks of rare, serious post-vaccine blood clots."((Pelley, L. (2021, April 23). //Canadians over 30 should be offered AstraZeneca-Oxford COVID-19 vaccine, advisory body recommends.// CBC News. http://archive.today/2021.04.24-073245/https://www.cbc.ca/news/health/astrazeneca-covid-19-vaccine-over-30-naci-1.6000052))
+On June 29, 2022, NACI issued guidance recommending "booster doses" of [[:COVID-19 vaccines]] for all "Canadians at increased risk of serious illness from [[COVID-19]]", regardless of how many doses they had previously received.((Boynton, S. (2022, June 19). //COVID-19 boosters recommended this fall ahead of future pandemic wave: NACI.// Global News. http://archive.today/2023.04.19-201142/https://globalnews.ca/news/8957899/naci-covid-19-boosters-fall-canada/))
+On March 3, 2023, NACI called for "high-risk individuals" to receive another booster dose in the spring.((National Advisory Committee on Immunization. (2023, March 3). //Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19.// Public Health Agency of Canada. https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-additional-covid-19-booster-dose-spring-2023-individuals-high-risk-severe-illness-due-covid-19/statement.pdf)) ((Pelley, L. (2023, March 3). //COVID-19 booster shots recommended for high-risk Canadians starting this spring.// CBC News. https://web.archive.org/web/20230419211957/https://www.cbc.ca/news/health/covid-booster-recommendations-1.6767057))
+===== Organization =====
+==== Members ====
+^  Current Members((Public Health Agency of Canada. (2022, April 22). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))  ^^^
 ^ Name  ^ Position  ^ Notes  ^
 | [[Shelley Deeks]]  | Chair  | Member of committees under [[World Health Organization]] and [[GAVI]], and funded by the [[Bill & Melinda Gates Foundation]].  |
@@ Line 49: / Line 62: @@
 | [[Kelly Robinson]]  | [[Marketed Health Products Directorate]], [[Health Canada]]  | -  |
 | [[Mireille Lacroix]]  | [[Public Health Ethics Consultative Group]]  | -  |
-==== Former ====
+| [[Nicole Forbes]]  | Secretariat((//Where Are They Now: Nicole Forbes.// (2020, November 20). BioCanRx. https://web.archive.org/web/20230316080334/https://biocanrx.com/now-nicole-forbes))  | -  |
+^  Former  ^^^
 ^ Name  ^ Position  ^ Notes  ^
 | [[Natalie Dayneka]]  | Member  | -  |
@@ Line 56: / Line 69: @@
 | [[Coleman Rotstein]]  | Member  | Funding from [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:Avir Pharma]], [[pharmaceutical_companies:Chimerix]], [[pharmaceutical_companies:Cidara Therapeutics]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Pendopharm]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Sunovion]], and [[pharmaceutical_companies:Teva]]  |
 | [[Althea House]]  | Manager  | -  |
+| [[Deborah Danoff]]  | Ex-officio representative for the [[Marketed Health Products Directorate]]  | -  |
 | [[Julie Emili]]  | Liaison representative for the [[College of Family Physicians of Canada]]  | -  |
+| [[Jennifer Pennock]]  | Ex-officio representative for the Surveillance and Epidemiology Division of the [[Centre for Immunization and Respiratory Infectious Diseases]] (CIRID) at [[Public Health Agency of Canada]]  | -  |
 | [[Robert Pless]]  | Ex-officio representative for the [[Biologics and Genetic Therapies Directorate]] at [[Health Canada]]  | -  |